Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

RPTPϵ promotes M2-polarized macrophage migration through ROCKII signaling and podosome formation.

Lapointe F, Turcotte S, Roy J, Bissonnette E, Rola-Pleszczynski M, Stankova J.

J Cell Sci. 2019 Nov 20. pii: jcs.234641. doi: 10.1242/jcs.234641. [Epub ahead of print]

PMID:
31722979
2.

Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.

Hamel-Côté G, Lapointe F, Véronneau S, Mayhue M, Rola-Pleszczynski M, Stankova J.

Cell Biosci. 2019 Jun 25;9:51. doi: 10.1186/s13578-019-0316-9. eCollection 2019.

3.

Role of Protein Tyrosine Phosphatase Epsilon (PTPε) in Leukotriene D4-Induced CXCL8 Expression.

Lapointe F, Turcotte S, Véronneau S, Rola-Pleszczynski M, Stankova J.

J Pharmacol Exp Ther. 2019 May;369(2):270-281. doi: 10.1124/jpet.118.255422. Epub 2019 Mar 13.

PMID:
30867226
4.

Regulation of platelet-activating factor-induced interleukin-8 expression by protein tyrosine phosphatase 1B.

Hamel-Côté G, Lapointe F, Gendron D, Rola-Pleszczynski M, Stankova J.

Cell Commun Signal. 2019 Mar 4;17(1):21. doi: 10.1186/s12964-019-0334-6.

5.

IL-33 Upregulates Cysteinyl Leukotriene Receptor Type 1 Expression in Human Peripheral Blood CD4+ T Lymphocytes.

Boudaud M, Turcotte S, Stankova J, Rola-Pleszczynski M.

J Immunol. 2018 Nov 1;201(9):2787-2798. doi: 10.4049/jimmunol.1701463. Epub 2018 Sep 21.

6.

Regulation of platelet-activating factor-mediated protein tyrosine phosphatase 1B activation by a Janus kinase 2/calpain pathway.

Hamel-Côté G, Gendron D, Rola-Pleszczynski M, Stankova J.

PLoS One. 2017 Jul 7;12(7):e0180336. doi: 10.1371/journal.pone.0180336. eCollection 2017.

7.

Correction: Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Lacraz G, Rakotoarivelo V, Labbé SM, Vernier M, Noll C, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier A, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, Langlois MF, Ilangumaran S, Ramanathan S.

PLoS One. 2016 Nov 8;11(11):e0166537. doi: 10.1371/journal.pone.0166537. eCollection 2016.

8.

Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Lacraz G, Rakotoarivelo V, Labbé SM, Vernier M, Noll C, Mayhue M, Stankova J, Schwertani A, Grenier G, Carpentier A, Richard D, Ferbeyre G, Fradette J, Rola-Pleszczynski M, Menendez A, Langlois MF, Ilangumaran S, Ramanathan S.

PLoS One. 2016 Sep 29;11(9):e0162995. doi: 10.1371/journal.pone.0162995. eCollection 2016. Erratum in: PLoS One. 2016 Nov 8;11(11):e0166537.

9.

Constitutively active Stat5b signaling confers tolerogenic functions to dendritic cells of NOD mice and halts diabetes progression.

Zerif E, Maalem A, Gaudreau S, Guindi C, Ramzan M, Véroneau S, Gris D, Stankova J, Rola-Pleszczynski M, Mourad W, Dupuis G, Amrani A.

J Autoimmun. 2017 Jan;76:63-74. doi: 10.1016/j.jaut.2016.09.001. Epub 2016 Sep 12.

PMID:
27634616
10.

Cellular signalling of cysteinyl leukotriene type 1 receptor variants CysLT₁-G300S and CysLT₁-I206S.

Yaddaden L, Véronneau S, Thompson MD, Rola-Pleszczynski M, Stankova J.

Prostaglandins Leukot Essent Fatty Acids. 2016 Feb;105:1-8. doi: 10.1016/j.plefa.2015.12.004. Epub 2015 Dec 21.

PMID:
26869085
11.

Interleukin-15-mediated inflammation promotes non-alcoholic fatty liver disease.

Cepero-Donates Y, Lacraz G, Ghobadi F, Rakotoarivelo V, Orkhis S, Mayhue M, Chen YG, Rola-Pleszczynski M, Menendez A, Ilangumaran S, Ramanathan S.

Cytokine. 2016 Jun;82:102-11. doi: 10.1016/j.cyto.2016.01.020. Epub 2016 Feb 8.

PMID:
26868085
12.

Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.

Côté-Bigras S, Tran V, Turcotte S, Rola-Pleszczynski M, Verreault J, Rottembourg D.

Endocrine. 2016 Jun;52(3):587-96. doi: 10.1007/s12020-015-0832-2. Epub 2015 Dec 23.

PMID:
26701678
13.

Differential Contribution of BLT1 and BLT2 to Leukotriene B4-Induced Human NK Cell Cytotoxicity and Migration.

Wang M, Mostafa El-Maghraby N, Turcotte S, Rola-Pleszczynski M, Stankova J.

Mediators Inflamm. 2015;2015:389849. doi: 10.1155/2015/389849. Epub 2015 Dec 1.

14.

Enhanced cysteinyl-leukotriene type 1 receptor expression in T cells from house dust mite-allergic individuals following stimulation with Der p.

Thivierge M, Turcotte S, Rola-Pleszczynski M, Stankova J.

J Immunol Res. 2015;2015:384780. doi: 10.1155/2015/384780. Epub 2015 Mar 31.

15.

Rapid evaluation of the absence of inflammation after rupture of membranes.

Berthiaume M, Rousseau É, Rola-Pleszczynski M, Pasquier JC.

J Matern Fetal Neonatal Med. 2014 Jun;27(9):865-9. doi: 10.3109/14767058.2013.829814. Epub 2013 Nov 13.

PMID:
23947432
16.

Effect of interleukin-6 receptor blockade on feto-maternal outcomes in a rat model of intrauterine inflammation.

Ouellet J, Berthiaume M, Corriveau S, Rola-Pleszczynski M, Pasquier JC.

J Obstet Gynaecol Res. 2013 Oct;39(10):1456-64. doi: 10.1111/jog.12089. Epub 2013 Jul 15.

PMID:
23855552
17.

CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.

Provost V, Larose MC, Langlois A, Rola-Pleszczynski M, Flamand N, Laviolette M.

J Leukoc Biol. 2013 Aug;94(2):213-22. doi: 10.1189/jlb.0212074. Epub 2013 Mar 26.

PMID:
23532518
18.

Time-dependent effect of in utero inflammation: a longitudinal study in rats.

Roy-Lacroix MÈ, Guérard M, Berthiaume M, Rola-Pleszczynski M, Crous-Tsanaclis AM, Pasquier JC.

J Matern Fetal Neonatal Med. 2013 May;26(8):789-94. doi: 10.3109/14767058.2012.755164. Epub 2013 Feb 11.

PMID:
23297691
19.

Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells.

Provost V, Langlois A, Chouinard F, Rola-Pleszczynski M, Chakir J, Flamand N, Laviolette M.

PLoS One. 2012;7(8):e43544. doi: 10.1371/journal.pone.0043544. Epub 2012 Aug 31.

20.

Rescue of internalization-defective platelet-activating factor receptor function by EBP50/NHERF1.

Dupré DJ, Rola-Pleszczynski M, Stankova J.

J Cell Commun Signal. 2012 Dec;6(4):205-16. doi: 10.1007/s12079-012-0175-1. Epub 2012 Aug 10.

21.

Platelet-activating factor induces Th17 cell differentiation.

Drolet AM, Thivierge M, Turcotte S, Hanna D, Maynard B, Stankovà J, Rola-Pleszczynski M.

Mediators Inflamm. 2011;2011:913802. doi: 10.1155/2011/913802. Epub 2011 Oct 13.

22.

Cysteinyl-leukotrienes induce vascular endothelial growth factor production in human monocytes and bronchial smooth muscle cells.

Poulin S, Thompson C, Thivierge M, Véronneau S, McMahon S, Dubois CM, Stankova J, Rola-Pleszczynski M.

Clin Exp Allergy. 2011 Feb;41(2):204-17. doi: 10.1111/j.1365-2222.2010.03653.x. Epub 2010 Dec 1.

PMID:
21121979
23.

Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.

Brochu-Bourque A, Véronneau S, Rola-Pleszczynski M, Stankova J.

J Pharmacol Exp Ther. 2011 Feb;336(2):431-9. doi: 10.1124/jpet.110.172411. Epub 2010 Oct 21.

PMID:
20966037
24.

Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.

Michaud F, Coulombe F, Gaudreault E, Paquet-Bouchard C, Rola-Pleszczynski M, Gosselin J.

PLoS One. 2010 Jul 30;5(7):e11908. doi: 10.1371/journal.pone.0011908.

25.

Transforming growth factor-beta1 in asthmatic airway smooth muscle enlargement: is fibroblast growth factor-2 required?

Bossé Y, Stankova J, Rola-Pleszczynski M.

Clin Exp Allergy. 2010 May;40(5):710-24. doi: 10.1111/j.1365-2222.2010.03497.x. Review.

PMID:
20447083
26.

Nuclear translocation of beta-actin is involved in transcriptional regulation during macrophage differentiation of HL-60 cells.

Xu YZ, Thuraisingam T, Morais DA, Rola-Pleszczynski M, Radzioch D.

Mol Biol Cell. 2010 Mar 1;21(5):811-20. doi: 10.1091/mbc.E09-06-0534. Epub 2010 Jan 6.

27.

Cysteinyl-leukotriene receptor type 1 expression and function is down-regulated during monocyte-derived dendritic cell maturation with zymosan: involvement of IL-10 and prostaglandins.

Thivierge M, Stankova J, Rola-Pleszczynski M.

J Immunol. 2009 Nov 15;183(10):6778-87. doi: 10.4049/jimmunol.0901800. Epub 2009 Oct 21.

28.

Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation.

Poisson C, Rollin S, Véronneau S, Bousquet SM, Larrivée JF, Le Gouill C, Boulay G, Stankova J, Rola-Pleszczynski M.

J Immunol. 2009 Aug 15;183(4):2747-57. doi: 10.4049/jimmunol.0802651. Epub 2009 Jul 20.

29.

Cysteinyl-leukotrienes in asthmatic airway smooth muscle cell hyperplasia.

Bossé Y, Stankova J, Rola-Pleszczynski M.

Ann Allergy Asthma Immunol. 2009 Jan;102(1):16-21. doi: 10.1016/S1081-1206(10)60102-0. Review.

PMID:
19205280
30.

Crucial implication of protein kinase C (PKC)-delta, PKC-zeta, ERK-1/2, and p38 MAPK in migration of human asthmatic eosinophils.

Langlois A, Chouinard F, Flamand N, Ferland C, Rola-Pleszczynski M, Laviolette M.

J Leukoc Biol. 2009 Apr;85(4):656-63. doi: 10.1189/jlb.0808492. Epub 2009 Jan 21.

PMID:
19164129
31.

Lipopolysaccharide and hypoxia/ischemia induced IL-2 expression by microglia in neonatal brain.

Girard S, Larouche A, Kadhim H, Rola-Pleszczynski M, Gobeil F, Sébire G.

Neuroreport. 2008 Jul 2;19(10):997-1002. doi: 10.1097/WNR.0b013e3283036e88.

PMID:
18580568
32.

Leukotriene D4 up-regulates furin expression through CysLT1 receptor signaling.

Thompson C, McMahon S, Bossé Y, Dubois CM, Stankova J, Rola-Pleszczynski M.

Am J Respir Cell Mol Biol. 2008 Aug;39(2):227-34. doi: 10.1165/rcmb.2007-0293OC. Epub 2008 Mar 6.

PMID:
18323532
33.

Interleukin-4 and interleukin-13 enhance human bronchial smooth muscle cell proliferation.

Bossé Y, Thompson C, Audette K, Stankova J, Rola-Pleszczynski M.

Int Arch Allergy Immunol. 2008;146(2):138-48. doi: 10.1159/000113517. Epub 2008 Jan 18.

PMID:
18204280
34.

FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia.

Bossé Y, Rola-Pleszczynski M.

Trends Mol Med. 2008 Jan;14(1):3-11. Epub 2007 Dec 4. Review.

PMID:
18055262
35.

Signaling by the cysteinyl-leukotriene receptor 2. Involvement in chemokine gene transcription.

Thompson C, Cloutier A, Bossé Y, Poisson C, Larivée P, McDonald PP, Stankova J, Rola-Pleszczynski M.

J Biol Chem. 2008 Jan 25;283(4):1974-84. Epub 2007 Nov 29.

36.

Leukotriene D4-induced, epithelial cell-derived transforming growth factor beta1 in human bronchial smooth muscle cell proliferation.

Bossé Y, Thompson C, McMahon S, Dubois CM, Stankova J, Rola-Pleszczynski M.

Clin Exp Allergy. 2008 Jan;38(1):113-21. Epub 2007 Nov 19.

PMID:
18028462
37.

Controversy surrounding the increased expression of TGF beta 1 in asthma.

Bossé Y, Rola-Pleszczynski M.

Respir Res. 2007 Sep 24;8:66. Review.

38.

Cytokine-leukotriene receptor interactions.

Rola-Pleszczynski M, Stankova J.

ScientificWorldJournal. 2007 Sep 1;7:1348-58. Review.

39.

Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor.

Dupré DJ, Thompson C, Chen Z, Rollin S, Larrivée JF, Le Gouill C, Rola-Pleszczynski M, Stanková J.

Cell Signal. 2007 Oct;19(10):2068-79. Epub 2007 Jun 13.

PMID:
17609120
40.

CysLT1 receptor engagement induces activator protein-1- and NF-kappaB-dependent IL-8 expression.

Thompson C, Cloutier A, Bossé Y, Thivierge M, Gouill CL, Larivée P, McDonald PP, Stankova J, Rola-Pleszczynski M.

Am J Respir Cell Mol Biol. 2006 Dec;35(6):697-704. Epub 2006 Jun 29.

PMID:
16809637
41.

Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.

Thivierge M, Stankova J, Rola-Pleszczynski M.

J Allergy Clin Immunol. 2006 May;117(5):1155-62. Epub 2006 Feb 21.

PMID:
16675346
42.

Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes.

Lamoureux J, Stankova J, Rola-Pleszczynski M.

J Allergy Clin Immunol. 2006 Apr;117(4):924-30. Epub 2006 Feb 7.

PMID:
16630953
43.

Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation.

Bossé Y, Thompson C, Stankova J, Rola-Pleszczynski M.

Am J Respir Cell Mol Biol. 2006 Jun;34(6):746-53. Epub 2006 Jan 26.

PMID:
16439802
44.

RNA-binding protein HuR is required for stabilization of SLC11A1 mRNA and SLC11A1 protein expression.

Xu YZ, Di Marco S, Gallouzi I, Rola-Pleszczynski M, Radzioch D.

Mol Cell Biol. 2005 Sep;25(18):8139-49.

45.

The anti-apoptotic effect of leukotriene B4 in neutrophils: a role for phosphatidylinositol 3-kinase, extracellular signal-regulated kinase and Mcl-1.

Pétrin D, Turcotte S, Gilbert AK, Rola-Pleszczynski M, Stankova J.

Cell Signal. 2006 Apr;18(4):479-87. Epub 2005 Jun 20.

PMID:
15970427
46.

Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis.

Gaudreault E, Stankova J, Rola-Pleszczynski M.

Prostaglandins Other Lipid Mediat. 2005 Jan;75(1-4):25-34.

PMID:
15789613
47.

Involvement of BLT1 endocytosis and Yes kinase activation in leukotriene B4-induced neutrophil degranulation.

Gaudreault E, Thompson C, Stankova J, Rola-Pleszczynski M.

J Immunol. 2005 Mar 15;174(6):3617-25.

48.

Inverse agonism: more than reverting constitutively active receptor signaling.

Dupré DJ, Rola-Pleszczynski M, Stanková J.

Biochem Cell Biol. 2004 Dec;82(6):676-80. Review.

PMID:
15674435
49.

Leukotrienes and isocyanate-induced asthma: a pilot study.

Lemiere C, Pelissier S, Tremblay C, Chaboillez S, Thivierge M, Stankova J, Rola-Pleszczynski M.

Clin Exp Allergy. 2004 Nov;34(11):1684-9.

PMID:
15544591
50.

Agonist-induced internalization of leukotriene B(4) receptor 1 requires G-protein-coupled receptor kinase 2 but not arrestins.

Chen Z, Gaudreau R, Le Gouill C, Rola-Pleszczynski M, Stanková J.

Mol Pharmacol. 2004 Sep;66(3):377-86.

PMID:
15322228

Supplemental Content

Loading ...
Support Center